Centrum Medyczne ENEL-MEDWAR:ENE 77 PS Ratio is 0.63 as of Jul. 08, 2026, which is 23% below its 10-year median of 0.82. GuruFocus rates WAR:ENE with a GF Score™ of 77/100 and a GF Value™ of zł25.06 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 658 Healthcare Providers & Services companies, Centrum Medyczne ENEL-MED ranks better than 75.23% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Centrum Medyczne ENEL-MED's share price is zł19.00.
Centrum Medyczne ENEL-MED's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was zł30.12. Hence, Centrum Medyczne ENEL-MED's PS Ratio for today is 0.63.
Good Sign:
Centrum Medyczne ENEL-MED SA stock PS Ratio (=0.63) is close to 5-year low of 0.6.
The historical rank and industry rank for Centrum Medyczne ENEL-MED's PS Ratio or its related term are showing as below:
WAR:ENE'
s PS Ratio Range Over the Past 10 Years
Min: 0.54 Med: 0.82 Max: 1.2
Current: 0.63
During the past 13 years, Centrum Medyczne ENEL-MED's highest PS Ratio was 1.20. The lowest was 0.54. And the median was 0.82.
WAR:ENE's PS Ratio is ranked better than 75.23% of 658
companies
in the Healthcare Providers & Services industry
Industry Median: 1.49
vs WAR:ENE: 0.63
Centrum Medyczne ENEL-MED SA has shown predictable revenue and earnings growth.
During the past 12 months, the average Revenue per Share Growth Rate of Centrum Medyczne ENEL-MED was 8.30% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 20.00% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 13.10% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 9.90% per year.
During the past 13 years, Centrum Medyczne ENEL-MED's highest 3-Year average Revenue per Share Growth Rate was 20.00% per year. The lowest was -0.40% per year. And the median was 9.80% per year.
Back to Basics: PS Ratio
Centrum Medyczne ENEL-MED (WAR:ENE) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Centrum Medyczne ENEL-MED PS Ratio Related Terms
Centrum Medyczne ENEL-MED PS Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Centrum Medyczne ENEL-MED's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Centrum Medyczne ENEL-MED PS Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Centrum Medyczne ENEL-MED's PS Ratio distribution charts can be found below:
* The bar in red indicates where Centrum Medyczne ENEL-MED's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Centrum Medyczne ENEL-MED's Share Price of today is zł19.00. Centrum Medyczne ENEL-MED's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was zł30.12.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Centrum Medyczne ENEL-MED (WAR:ENE) has a PS Ratio of 0.63 as of Jul. 08, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Centrum Medyczne ENEL-MED and its competitors. This is 23% below median its historical median of 0.82. Over the past decade, Centrum Medyczne ENEL-MED's PS Ratio has ranged from 0.54 to 1.20. According to the industry distribution chart, Centrum Medyczne ENEL-MED ranks #163 out of 658 companies in the Healthcare Providers & Services industry, placing it in the top 24.8%.
Is Centrum Medyczne ENEL-MED's PS Ratio too high?
Centrum Medyczne ENEL-MED's current PS Ratio of 0.63 is 23% below median its 10-year median of 0.82. Over the past 10 years, this metric has ranged from a low of 0.54 to a high of 1.20. The Healthcare Providers & Services industry median PS Ratio is 1.49. Centrum Medyczne ENEL-MED's value of 0.63 is 57.7% below this industry median. Based on the distribution chart, Centrum Medyczne ENEL-MED ranks #163 out of 658 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Centrum Medyczne ENEL-MED has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Centrum Medyczne ENEL-MED's PS Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Centrum Medyczne ENEL-MED ranks #163 out of 658 companies for PS Ratio. This places Centrum Medyczne ENEL-MED in the top 25% of its industry — outperforming the majority of peers. The industry median PS Ratio is 1.49. Centrum Medyczne ENEL-MED's value of 0.63 is 57.7% below this benchmark. Historically, Centrum Medyczne ENEL-MED's own PS Ratio has ranged from 0.54 to 1.20 over the past decade. While the company's 10-year median is 0.82 vs. the industry median of 1.49, Centrum Medyczne ENEL-MED has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Healthcare Providers & Services company?
The median PS Ratio among Healthcare Providers & Services companies is 1.49, based on 658 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Centrum Medyczne ENEL-MED's current PS Ratio of 0.63 is 57.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Centrum Medyczne ENEL-MED and its competitors. For the Healthcare Providers & Services industry, the median PS Ratio is 1.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Centrum Medyczne ENEL-MED's current PS Ratio is 0.63, which is 23% below median its own 10-year median of 0.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Centrum Medyczne ENEL-MED stock overvalued right now?
Based on GuruFocus' analysis, Centrum Medyczne ENEL-MED (WAR:ENE) is currently considered Modestly Undervalued. The stock's GF Value™ is zł25.06, compared to a current price of zł19.00 — trading 24.2% below its estimated fair value. The current PS Ratio is 0.63, which is 23% below median its 10-year median of 0.82 and 57.7% below the Healthcare Providers & Services industry median of 1.49. Centrum Medyczne ENEL-MED's overall GF Score™ is 77/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Centrum Medyczne ENEL-MED (WAR:ENE), the current PS Ratio is 0.63 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Centrum Medyczne ENEL-MED (WAR:ENE) Overvalued in 2026?
Based on GuruFocus' analysis, Centrum Medyczne ENEL-MED stock appears to be undervalued.
The current stock price of zł19.00 is trading 24.2% below its estimated GF Value™ of zł25.06.
GuruFocus considers Centrum Medyczne ENEL-MED to be Modestly Undervalued.
Key valuation signals for WAR:ENE:
PS Ratio: 0.63 (23% below median its 10-year median of 0.82)
GF Value™: zł25.06 vs. price of zł19.00 (24.2% below fair value)
Industry Position: 57.7% below the Healthcare Providers & Services median (#163 of 658)
No single metric tells the full story. See the WAR:ENE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Centrum Medyczne ENEL-MED SA is engaged in providing medical services throughout Poland region. The company is involved in providing various services that are dentistry, picture diagnosis, clinics, subscription for companies, and medical insurance. It also provides hospitals, aesthetic medicines, and sports medicine. The company's treatment cycle consists of consultation, diagnosis, hospitalization, surgery, and rehabilitation.
77GF Score
Get the complete analysis for WAR:ENE
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:ENE has been successfully added to your 
